It appears that light-to-moderate alcohol consumption (LMAC) can lower the risks of prevalent and incident type 2 diabetes mellitus (T2DM) in individuals without nonalcoholic fatty liver disease (NAFLD), suggests a study. However, LMAC increases the risk of T2DM in those with NAFLD.
Transcutaneous neuromodulation (TN) at acupoint Zusanli (ST36) appears to be more potent than TN at posterior tibial nerve (PTN) in the treatment of constipation and its related symptoms and rectal sensation, a study has shown.
The 10-day concomitant nonbismuth quadruple regimen for the treatment of Helicobacter pylori infection remains the most efficient strategy as compared with the 14-day therapy, results of a Greek study have shown.
The combination of ivabradine and carvedilol improves left ventricular diastolic dysfunction (LVDD), achieves targeted heart rate reduction (THR) more often, and reduces the risk of encephalopathy, leading to improved survival in patients with cirrhosis, reveals a study.
Oral administration of the nonabsorbable OPRX-106 shows potential in the treatment of mild-to-moderate ulcerative colitis (UC), delivering favourable anti-inflammatory immune modulation without concurrent immune suppression, according to the results of a phase IIa trial.
Use of adalimumab or infliximab in biologic-naïve patients with inflammatory bowel disease (IBD) delivers comparable rates of corticosteroid-free remission, as shown by a study presented at the Advances in Inflammatory Bowel Disease (AIBD) Conference 2019.